Stocks in play: Victory Square Technologies
Announces that its portfolio company, Hydreight Technologies Inc. (TSXV: NURS) has received final approval for its qualifying transaction as principally described in its filing statement dated November 10, 2022, from the TSX Venture Exchange and its common shares have commenced trading on the TSXV under the symbol 'NURS' effective at market open on December 1, 2022. Victory Square Technologies shares C.VST are trading unchanged at $0.14.
Read:
Latest Set of FDA Fast Track Designations Causing Optimism in Biotech Sector
Biotech Sector to Unveil New Data and Developments at 2022 SABCS in San Antonio
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America